4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001437749-22-021367
Pres. Diagnostics & Genom acquired 663 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelderman Kim Pres. Diagnostics & Genom | 2022-08-23 | Option exercise | +663 | $150.78 | $99,967 | 3,801 | D |
| Derivatives | |||||||
| Kelderman Kim Pres. Diagnostics & Genom | 2022-08-23 | Option exercise · Stock Option (Right to Buy) | −663 | 6,848 | D | ||
Loading xslF345X03/rdgdoc.xml…